300238 冠昊生物
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资48-98.93%4,49016,92517,40659,063
投资性房地产8,235-3.90%8,5699,01400
固定资产311,610-2.48%319,542161,958182,734199,940
在建工程3,28729.31%2,54273,9912,8022,412
无形资产73,7841.49%72,70278,66087,49264,144
商誉0--000214,330
其他非流动资产76,810-4.90%80,76570,76880,950123,435
473,775-3.04%488,610411,317371,383663,323

流动资产
货币资金141,43532.45%106,780105,136126,280159,308
应收账款47,970-19.44%59,54661,14371,976106,706
存货83,4996.42%78,45971,60161,677140,548
其他流动资产27,82832.48%21,00529,39838,95628,851
300,73213.15%265,790267,278298,889435,414

流动负债
短期借款11,007-45.01%20,01524,51949,04851,564
应付票据0--0000
应付帐款13,968-60.82%35,65029,3232,1641,881
其他流动负债127,3244.08%122,327118,874137,777208,826
152,298-14.43%177,991172,716188,989262,270
流动资产净值148,43569.06%87,79994,562109,900173,144
资产总额减流动负债622,2097.95%576,409505,879481,284836,467

非流动负债
长期借款100,95032.83%76,00012,01500
应付债券0--0000
其他非流动负债27,766-15.39%32,81737,60350,34088,305
128,71618.29%108,81749,61850,34088,305

总权益
    实收股本265,1560.00%265,156265,156265,156265,156
    储备项目306,96610.74%277,202255,438220,188518,765
股东权益572,1215.49%542,358520,594485,344783,921
非控股权益(78,628)5.17%(74,766)(64,334)(54,400)(35,759)